Vicky Hahne Net Worth

Ms. Vicky Hahne biography

Vicky Hahne is the Chief Financial Officer at Celcuity Inc.

What is the salary of Ms Hahne?

As the Chief Financial Officer of Celcuity Inc, the total compensation of Ms Hahne at Celcuity Inc is $177,650. There are 2 executives at Celcuity Inc getting paid more, with Dr. Lance G. Laing having the highest compensation of $333,900.

How old is Ms Hahne?

Ms Hahne is 55, she's been the Chief Financial Officer of Celcuity Inc since . There are 5 older and no younger executives at Celcuity Inc. The oldest executive at Celcuity Inc is Dr. John R. MacDonald Ph., Dabt, 66, who is the Sr. VP of R&D.

What's Ms Hahne's mailing address?

Vicky's mailing address filed with the SEC is 16305 36TH AVENUE N., SUITE 100, MINNEAPOLIS, MN, 55446.

Insiders trading at Celcuity Inc

Over the last 7 years, insiders at Celcuity Inc have traded over $452,378 worth of Celcuity Inc stock and bought 317,370 units worth $2,387,116 . The most active insiders traders include Brian F. Sullivan, Richard Nigon, and Polly A. Murphy. On average, Celcuity Inc executives and independent directors trade stock every 67 days with the average trade being worth of $147,164. The most recent stock trade was executed by Richard E Buller on 23 August 2024, trading 350 units of CELC stock currently worth $5,933.

What does Celcuity Inc do?

celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.

Celcuity Inc executives and stock owners

Celcuity Inc executives and other stock owners filed with the SEC include:

• Dr. Lance G. Laing,
  Co-Founder, Chief Science Officer, VP, Sec. & Director
• Brian F. Sullivan,
  Co-Founder, Chairman & CEO
• Vicky Hahne,
  Chief Financial Officer
• Igor Gorbatchevsky,
  MD & VP of Clinical Devel.
• Dr. Arthur P. DeCillis M.D.,
  Chief Medical Officer
• Bernhard Lampert Ph.D.,
  Head of CMC
• Marie DeGayner Kuker,
  Head of Regulatory
• Sheri Smith,
  Acting Head of Clinical Operations
• Dr. John R. MacDonald Ph., Dabt,
  Sr. VP of R&D
• Dr. Arthur P. DeCillis,
  Chief Medical Officer
• Eric Lindquist,
  Chief Bus. Officer
• Vicky Hahne,
  Chief Financial Officer
• Richard Nigon,
  Director
• David Dalvey,
  Director
• Maureen Therese Cronin,
  Director
• Leo Furcht,
  Director
• Richard E Buller,
  Director
• Polly A. Murphy,
  Director
• Lance G. Laing,
  Chief Science Officer
• Brian F. Sullivan,
  Chief Executive Officer